announces that the results of a Phase 3 clinical study of mazdutide , a dual glucagon (GCG)/glucagon-like peptide-1 (GLP-1) receptor agonist, in Chinese adults with overweight or obesity (GLORY-1 ...

But with promising early results from a phase 3 study in certain patients, the checkpoint inhibitor may have found its place. At a pre-specified interim analysis of Merck’s phase 3 Keynote-B96 ...

We look forward to progressing our fully owned asset PN-881 in human clinical studies in Q4 2025." Editor's notes: ICONIC-TOTAL is a Phase 3 randomized controlled trial (RCT) evaluating the efficacy ...

Amgen has reported positive phase 3 results with its biosimilar version of AstraZeneca/Alexion's blockbuster rare disease drug Soliris, setting up a regulatory filing with the FDA. The biotech has ...

Boehringer Ingelheim has said it will take its obesity drug candidate survodutide into a phase 3 programme later this year. The glucagon/GLP-1 receptor dual agonist – partnered with Zealand ...

Luton, Bedfordshire, United Kingdom, May 29, 2025 (GLOBE NEWSWIRE) -- The vehicle-to-grid (V2G) market is set for significant expansion, projected to grow at a CAGR of 30.2% between 2025 and 2033 ...

Luton, Bedfordshire, United Kingdom, May 29, 2025 (GLOBE NEWSWIRE) -- The vehicle-to-grid (V2G) market is set for significant expansion, projected to grow at a CAGR of 30.2% between 2025 and 2033, ...

Phase 2A, the second operational leg of Mumbai's first totally underground metro corridor, the Aqua Line (Metro Line 3), has opened, offering a quick and direct underground connection between the ...

Neuronata-R® holds Orphan Drug Designation from both the U.S. FDA (2018) and the EMA (2019). CorestemChemon completed a Phase 2 trial (NCT01363401) in 2014 and its Phase 3 trial (NCT04745299) in 2024; ...

qDepartment of Hepatogastroenterology and Digestive Oncology, Nancy University Hospital, University of Lorraine, Vandoeuvre-lès-Nancy, France rDepartment of Gastroenterology and Digestive Oncology, ...